Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
16 de mayo de 2016 actualizado por: Bijan Najafi, University of Arizona
Explore the benefit of the game-based virtual reality system in improving lower extremity kinematics and balance in patients suffering from disease/disorders including Diabetes, Cancer, Multiple Sclerosis, Arthritis, Parkinson's disease, Cognitive Disorders, Brain Injury, Stroke or Frailty.
A four to six weeks of training with 2 training session/week will be provided.
Descripción general del estudio
Estado
Desconocido
Condiciones
Intervención / Tratamiento
Descripción detallada
Individuals suffering from certain disorders/diseases including diabetes, arthritis, cancer, osteoarthritis, stroke, Parkinson's disease, cognitive impairment or brain Injury are more likely to experience a fall or a fall-related injury than healthy individuals during to impaired postural stability or diminished joint perception.
Under certain circumstance they may also experience pain, depression, anxiety, and a decreased quality of life.
The investigators' research has been designed to provide exercise training using non-invasive body-worn sensors (similar to those used in an iPhone®) to provide real-time visual information about joint motion in a virtual environment.
These sensors will be worn using a vest, t-shirt or elastic band.
The investigators will, 1) assess changes in participant's perception of lower extremity position while they perform these exercises; 2) motivate and guide simple exercise performance in the clinic/home, using an interactive game-like scheme; and 3) assess changes in participant's postural stability and gait as a result of provided exercise training.
The information gathered will provide new understanding about more helpful rehabilitation strategies that improve postural stability in patient population.
Tipo de estudio
Intervencionista
Inscripción (Anticipado)
200
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Arizona
-
Tucson, Arizona, Estados Unidos, 85724
- Reclutamiento
- University of Arizona
-
Contacto:
- Bijan S Najafi, PhD
- Número de teléfono: 713-798-0477
- Correo electrónico: najafi.bijan@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
Diagnosis of:
- diabetes
- cancer
- multiple sclerosis
- arthritis
- Parkinson's disease
- cognitive disorders
- brain injury
- frailty
- stroke
Exclusion Criteria:
- conditions not related to specific disorders affecting balance and gait
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Exergame
inertial sensor based system (wearable sensors, LEGSys, Biosensics LLC) will be used for balance training with computerized feedback.
The balance training program is focused on lower extremities including ankle joint exercise and virtual obstacle crossing tasks.
|
Subjects will perform progressive and computerized foot and ankle exercises which include weight shifting, ankle reaching task while standing, and virtual obstacle crossing task (i.e.
balancing on single leg) using wearable sensors technology (Exergaming) equipment).
Subjects will perform these exercises for 4-6 weeks, twice per week.
The duration of exercise per session is anticipated to be 30-45 minutes.
Otros nombres:
|
|
Comparador activo: Home based balance training
The control group will ask to perform a home based program includes similar exercise components as proposed in the experimental group, however without computerized feedback.
Exercises include postural balance tasks, such as backward and forward weight shifting, as well as dynamic balance exercises, such as marching in place (comparable to virtual obstacle crossing in experimental group).
|
Subjects in the control group will ask to perform a standard home based balance program for 4-6 weeks.
The home based program includes similar exercise components as proposed in the experimental group, however without computerized feedback and Exergaming equipment.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Balance
Periodo de tiempo: 4-6 weeks
|
Balance will be quantified by measuring area of sway of center of mass (with unit of cm2) during quite standing according to Romberg's protocol and using validated instrument (BalanSens, Biosensics, MA, USA)
|
4-6 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in gait Speed
Periodo de tiempo: 4-6 weeks
|
Gait Speed (with unit of m/sec) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking
|
4-6 weeks
|
|
Change in Stride length
Periodo de tiempo: 4-6 weeks
|
Stride Length (with unit of meter) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking
|
4-6 weeks
|
|
Change in Stride time
Periodo de tiempo: 4-6 weeks
|
Stride time (with unit of second) will be measured using validated wearable technology (LEGSys, Biosensics, MA, USA) and during walking with habitual and fast speed walking
|
4-6 weeks
|
|
Change in number of walking steps per day
Periodo de tiempo: 4-6 weeks
|
Average of walking steps (no unit) per day will be measured during 48 hours of daily physical activity monitoring using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
|
Change in average of walking bout
Periodo de tiempo: 4-6 weeks
|
Daily average of walking bout (continuous walking without stop, with unit of steps) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
|
Change in average of standing bout
Periodo de tiempo: 4-6 weeks
|
Daily average of standing bout (continuous standing without changing in posture with unit of seconds) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
|
Change in average of longest walking bout
Periodo de tiempo: 4-6 weeks
|
Daily average of longest walking bout (longest continuous walking without stop per day, with unit of steps) will be measured over 48 hours monitoring of physical activity using a validated wearable sensor technology (PAMSys, Biosensics, MA, USA)
|
4-6 weeks
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de septiembre de 2014
Finalización primaria (Anticipado)
1 de diciembre de 2016
Finalización del estudio (Anticipado)
1 de agosto de 2017
Fechas de registro del estudio
Enviado por primera vez
8 de junio de 2015
Primero enviado que cumplió con los criterios de control de calidad
16 de mayo de 2016
Publicado por primera vez (Estimar)
19 de mayo de 2016
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
19 de mayo de 2016
Última actualización enviada que cumplió con los criterios de control de calidad
16 de mayo de 2016
Última verificación
1 de mayo de 2016
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Desordenes mentales
- Enfermedades Cerebrales
- Enfermedades del Sistema Nervioso Central
- Enfermedades del Sistema Nervioso
- Enfermedades del sistema inmunológico
- Enfermedades Autoinmunes Desmielinizantes, SNC
- Enfermedades Autoinmunes del Sistema Nervioso
- Enfermedades desmielinizantes
- Enfermedades autoinmunes
- Heridas y Lesiones
- Trastornos neurocognitivos
- Trastornos Parkinsonianos
- Enfermedades de los ganglios basales
- Trastornos del movimiento
- Sinucleinopatías
- Enfermedades neurodegenerativas
- Trauma craneoencefálico
- Trauma, Sistema Nervioso
- Esclerosis múltiple
- Enfermedad de Parkinson
- Lesiones Cerebrales
- Trastornos cognitivos
Otros números de identificación del estudio
- 1409482826
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .